Advanced Renal Cell Carcinoma: Key Principles for Optimal First-Line Decision-Making

In this closing segment, the panel summarizes key principles guiding first-line treatment decisions in advanced renal cell carcinoma. Dr. Elizabeth Plimack emphasizes the importance of remaining adaptable to emerging clinical data while tailoring treatment to the individual patient, with the goal of maximizing the potential for durable, long-term outcomes. She highlights the need to anticipate treatment course, including dose adjustments and future therapeutic options. Dr. Brian Rini reinforces the importance of understanding disease biology, including tumor burden and pace of progression, to guide the intensity of treatment. He stresses that first-line therapy represents the best opportunity for long-term disease control or remission, and clinicians should focus on optimizing this phase rather than planning ahead for subsequent therapies. Dr. Thomas Powles concludes by underscoring that effective management of treatment, including toxicity monitoring and appropriate interpretation of imaging, is critical to achieving optimal outcomes in advanced renal cell carcinoma.